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1. Introduction
Endoscopy and histopathology are two morphological diagnostic procedures which allow
direct examination of organs with optical methods. They can detect abnormalities of the
normal anatomy and histology and provide a precise diagnosis. Based on the information
derived from these investigations an adequate treatment, either medical or surgical can be
proposed. The optical resolution of both methods is different. Classical endoscopy is using
essentially the naked eye observation of the tissue which allows a diagnosis of an ulcer or a
raised lesion for instance, while histopathology is reaching the cellular and sub-cellular level.
The new endoscopic techniques however do increase the optical resolution. The major
contributions of histopathology to endoscopy are situated in inflammatory and neoplastic
diseases. Histopathology allows a more precise diagnosis of the type of inflammation and a
better classification of tumours. This has again an impact upon treatment. For the diagnosis,
histopathology can be an essential element, as illustrated by gluten sensitive enteropathy
(although serology is also an essential element) or by identification of specific pathogens such
as Giardia lamblia, Mycobacterium avium, cryptosporidia.... Histopathology can further be
important for the confirmation of a diagnosis but very often it will provide a more precise
diagnosis by determining the aetiology of inflammation as illustrated by autoimmune gastritis,
or by typing a tumour (adenocarcinoma or lymphoma). In addition, histopathology can
provide essential elements for further therapy strategy by demonstrating the presence or
absence of risk factors for residual tumour in polypectomy or endoscopic mucosal resection.
Indirectly, it offers the possibility of using additional techniques such as biomarkers for
dysplasia and cancer or the demonstration of mutations such as KRAS in colorectal cancer or
HER2 amplification in oesophageal and gastric cancer.[1, 2].These applications can have
important therapeutic consequences. It has been shown for instance that activating mutations
of the KRAS gene are associated with poor response to anti-EGFR therapies and that patients
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with tumors that had high levels of HER2 protein expression derived the greatest benefit from
treatment with trastuzumab..
2. What is the influence of endoscopy on the diagnostic yield of
histopathology?
2.1. General requirements for the endoscopist and the pathologist
A close collaboration between the endoscopist and the pathologist is essential for an accurate
diagnosis. This imposes on each of the partners some constraints.
Overall the endoscopist should provide the pathologists with a copy of the endoscopy report
mentioning the sites of the biopsies, a macroscopic description of the lesions if present and the
adjacent mucosa and essential clinical information such as the age of the patient, the immune
status of the patient, duration of symptoms and treatment if any.
The pathologist should provide information of the quality of the biopsies (number and size
and depth of the samples) in order to avoid false conclusions, a degree of probability of his
initial diagnosis and if needed suggest particular conditions for further sampling or ancillary
techniques such as immune histochemistry. Contentious cases should be selected for clinic
pathological discussion.[3]
2.2. Sampling of biopsies
The diagnostic yield of histopathology depends upon the experience of the pathologist but
also upon the quality of the biopsy samples and sampling error. The quality of the samples is
influenced by a variety of elements such as the size and shape of the biopsy forceps, the nature
and location of the disease, the experience of the endoscopist and the number of samples.
During endoscopy samples can be obtained by way of different techniques. These include
pinch biopsy, suction biopsy with a multipurpose tube (which provides larger samples), brush
cytology, endoscopic fine needle aspiration (offering material from deep areas in the lesion)
and snare excision or strip biopsy.
Pinch biopsy is the most common technique. Several types of biopsy forceps are available. A
distinction can be made between those with elliptical and those with round cups. Generally
the samples obtained with elliptical cups are larger. A forceps with round cups may be more
appropriate for children in order to avoid complications. The size of the biopsy forceps
determines partly the size (surface and depth) of the samples. The small forceps has a width
of 1.8 mm when opened. The average forceps has a 2.4 mm diameter and allows to obtain
samples containing the muscularis mucosae (and upper submucosa) in 60% of the cases. The
larger Jumbo forceps has a 3.4 mm diameter. Samples obtained with this forceps are larger,
but, they usually contain not more submucosa and the risk of complications (perforation and
bleeding) may be more important, whereas it is minimal with the smaller forceps (if the patient
has normal coagulation). A forceps can have a central spike so that it stays in position in the
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mucosa, during the procedure. The spike can induce artefacts which should not be confused
with erosions.
The anatomic location or certain types of lesions may be the reason why samples are of less
good quality or superficial in nature. This is often so in areas immediately distal to a stricture,
and at the papilla of Vater in the duodenum. The extrahepatic bile ducts and the pancreatic
duct are other areas where biopsies are more difficult to obtain and hence usually smaller. If
the biopsies of the papilla are taken following sphincterotomy, coagulation artefacts are likely
to be present.
In  order  to  obtain  samples  of  appropriate  depth  air  insufflation  during  the  endoscopic
examination should be limited. When over-insufflation occurs the mucosa is stretched and
pushed towards the underlying submucosa and the samples are likely to be more superficial.
The samples obtained with a forceps are usually limited to the mucosa. Normally they are not
suitable for the assessment of submucosal or deeper lesions. This means that they are not good
for instance for a diagnosis of “vasculitis”, except for small vessel disease. By the use of a
"burrowing technique" whereby several biopsies are taken in the same area information of
deeply situated lesions can eventually be obtained. An alternative are samples obtained with
endoscopic ultrasound guided fine needle aspiration. They are usually smaller but they permit
both morphologic and cytologic analysis of lesions within or adjacent to the gastrointestinal
(GI) tract. They can be used for the assessment of neoplastic lesions, but because of the small
size, they are not good for conditions such as vasculitis.[4]
2.3. Larger samples
Larger samples are obtained with endoscopic mucosal resection (EMR) or endoscopical
submucosal resection (ESD) and snare polypectomy. These samples must be handled
adequately by the endoscopist or/and in the pathology lab. The histopathological interpreta‐
tion of these samples provides important information for subsequent management and
assessment of the risk for residual cancer. A correct diagnostic process involves, tumour
differentiation, precise determination of deep infiltration, lymphatic permeation and adequate
determination of the section margin. Identification of this area is easy if the lesion is adequately
oriented. In the case of polypectomy, the endoscopist could identify the section margin with
India ink or with a pin if the lesion is removed in one piece. The specimen will be cut along
the marker. (Fig. 1) In the case of EMR /ESD, ideally, the specimen should be oriented, pinned
and stretched on card board in the endoscopy unit.(Fig 2) If the specimen is not removed in
one piece, reconstruction of the specimens should be attempted. Painting of the base and
margins is useful, as tumour extension to the deep margin implies surgery and remnants of
the neoplastic epithelium at the lateral margins indicate re-excision or postoperative
destruction.[5, 6] Good communication between the pathologist and the clinicians is important
for the assessment of the efficacy of the treatment and for the design of the strategy of the
additional treatment which is based upon the depth of invasion of the lesion. If the resection
has been performed in piecemeal fashion and the specimen is received in two or more
fragments, it may be impossible to determine the true margin of resection, if the endoscopist
did not attempt to identify the true margin or placed the true margin in a separate container.[7]
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 (A) 
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Figure 1. Polypectomy specimen correctly oriented using a needle showing the top (upper right) and the base (lower
right) (A) and cut along the orientation (B)
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 (A) 
(B
Figure 2. Specimen from endoscopic mucosal resection pinned out and stretched (A) and cut at all levels (B)
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2.4. Endoscopic ultrasound-guided fine-needle aspiration biopsy
Endoscopic ultrasound guided fine needle aspiration has become the most accurate modality
for characterization of pancreatic cystic and solid lesions, differential diagnosis of indetermi‐
nate masses and locoregional staging of some digestive cancers (gastric, oesophagus, pancreas,
biliary tract…). It should be performed in the primary mass but also in distant lymph nodes,
or metastatic locations. EUS-FNA has a high sensitivity, specificity, positive predictive value
and accuracy in the assessment of biliopancreatic tumours. The performance of this technique
is dependent on the endoscopist and cytopathologist experience. It is well known that accuracy
of FNA increases when the technique is performed by an experienced clinician and when the
slides are reviewed by an experienced cytopathologist the collaboration between these two
physicians is also very important.[8]
2.5. Number of samples
Several studies have shown that the diagnostic yield of histopathology is increased and
sampling error is decreased by increasing the number of biopsies. This has been demonstrated
for inflammatory diseases such as chronic idiopathic inflammatory bowel diseases (IBD) and
for neoplastic diseases.[9] Therefore different guidelines for endoscopic sampling in various
diseases have been developed.[10-12] ECCO guidelines propose to obtain “multiple” biopsies
from five sites around the colon (including the rectum) and the ileum for a reliable diagnosis
of Crohn’s disease. Multiple biopsies imply a minimum of two samples from each site (Table)
This is also true for a diagnosis of collagenous or lymphocytic colitis. Thickening of the
subepithelial collagen table in collagenous colitis is indeed not homogeneous. Such guidelines
are very important in clinical practice. They limit sampling error and compensate for the small
size of the samples. However, the introduction of new technologies and modern endoscopes
including zoom endoscopy, high magnification endoscopy and more sophisticated techniques
such as laser-scanning confocal endoscopy and endo-cytoscopy (microscope incorporated in
the endoscope) will change practice in the future by offering the possibility of targeted biopsies.
In a recent study at our institute, chromo endoscopy (CE) and narrow band imaging (NBI)
were used to detect dysplasia in ulcerative colitis. A total of 268 raised lesions were detected
in 83 patients (156 lesions in 45 patients with CE and 112 lesions in 38 patients with NBI). On
histology, 44 were shown to be neoplastic (26 lesions in 10 patients with CE and 18 lesions in
12 patients with NBI): 1 adenocarcinoma, 1 high grade dysplasia, 2 dysplasia associated lesion
or mass, and 17 adenoma like mass. The new endoscopic techniques are also narrowing the
gap between endoscopy and pathology. Laser scanning endoscopy provides a microscopy-
level image without obtaining a biopsy specimen. Endo-cytoscopy is based on the technology
of light contact microscopy. The tip of an endoscope is placed in direct contact with a dye-
stained surface and then the surface is scanned with condensed normal white light, producing
cellular-level imaging. Laser endoscopy increases the real time diagnostic yield and can be
used to confirm dysplasia with high accuracy. Bio-endoscopy is another technique under
consideration. It involves the use of monoclonal antibodies labelled with a fluorescent tag of
reporter probes (molecules that enter cells) or fluorescent DNA probes for FISH in order to
detect in situ molecular changes or chromosomal instability.[13-16]
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Table 1. Recommendations for biopsy strategies in inflammatory conditions of the gastrointestinal tract
While these new techniques can offer real time images and diagnosis, the interpretation of the
images still depends on the morphological features of the lesions, as observed with microscopy
and some lesions like sessile serrated adenomas are still beyond the reach of real time
diagnosis. The endoscopist must therefore have a thorough knowledge of pathology.
3. Specimen handling
Specimen handling should be done carefully in order to allow optimal diagnostic work up. It
implies proper identification of the patient, including the age, specification of the site of origin,
fixation and in some instances, orientation. Adequate fixation by an appropriate fixative is
Endoscopy and Histopathology
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central to any histological preparation. Tissue that is inadequately fixed will lead to difficulties
for cutting, staining and performing ancillary tests. These problems are not correctable in a
later stage. Unfortunately there is no "all purpose" fixative. The choice of the appropriate
fixative is based on the type of tissue being fixed and on projected needs for ancillary tests,
such as special stains, immune histochemistry, in situ hybridization, and electron microscopy.
Routine Haematoxylin and eosin staining of multiple sections is adequate in most cases but
insufficient in particular situations such as a diagnosis of Hirschsprung's disease or metabolic
storage disorders.(Fig 3) For such indications freshly frozen tissue for enzyme histochemistry
for the demonstration of acetylcholinesterase activity in nerves, or the identification of fat are
needed or tissue fixed in glutaraldehyde for transmission electron microscopy. If possible, the
endoscopist should be aware of the clinical indication for the biopsy, and, if necessary contact
the pathology laboratory in order to know whether a special fixation is needed. In general
formalin (10% neutral buffered formalin, i.e. a 10% v/v solution of 40% formaldehyde gas in
water) allows good fixation and application of immune histochemistry as well as molecular
analyses. Bouin fixation should therefore be “proscribed”. Furthermore it is important to
control the duration of fixation. Samples need to be immersed in the fixative immediately and
the duration of fixation can have an impact on the quality of the results of ancillary techniques
such as immune histochemistry. A minimum of 6 hours and no longer than 48 hours is
recommended for adequate molecular biology procedures such as for HER2 immune
histochemistry in gastric cancer.[17] Frozen sections will allow application of most ancillary
techniques. Freezing must be done properly (by immersion in liquid nitrogen for instance) and
quickly in order to avoid the formation of ice cristals. Rapid adequate freezing and prevention
of tissue degeneration is equally essential when molecular techniques based on DNA analysis
are considered.
Figure 3. Multiple sections from multiple endoscopic biopsies allow a more complete microscopic analysis
Proper orientation of the tissue samples is important for a correct diagnosis of malabsorptive
states such as celiac disease, where the ratio villous height – crypt depth must be assessed and
for specimens from endoscopic resections of polyps or early neoplastic lesions.
Endoscopy10
4. Immune histochemistry and other ancillary techniques
In most instances histopathology identifies the nature of the lesion or tumour. Neoplastic –
malignant - tumours are most frequently epithelial. A smaller number is neoplastic but non-
epithelial, and includes lymphoproliferative disorders and soft tissue tumors. Histopathology
is an adequate tool for solving differential diagnostic problems and typing of tumours. The
differential diagnosis between anaplastic carcinomas, large-cell lymphoma, epithelioid
stromal tumours and neuroendocrine tumours can be difficult but immunohistochemical
stainings with antibodies against cytokeratins (CK), a marker for epithelial cells, CD117 a
marker for gastrointestinal stromal tumors, chromogranin, a marker for endocrine cells and a
common leucocyte marker can solve the problem. Antibodies to intermediate filaments such
as the CKs can be potentially useful in other situations. CKs comprise a subfamily of more than
20 members. The relatively limited distribution of some CKs such as CK7 and CK20 and
examination of coordinate expression of these two CKs can help in the differential diagnosis
of carcinomas of unknown primary site.(Fig. 4)
Figure 4. Microphotograph showing a rectal biopsy with Cytokeratin 7 positive immunohistochemistry demonstrating
the presence of a breast cancer metastasis.
Immune histochemistry and cytogenetic analysis is essential for the management of
lymphomas. Primary intestinal lymphomas should be sub-typed in B cell and T cell
malignancies and classified according internationally validated classifications such as the
recently published WHO.
Evaluating the proliferation fraction of the tumour cells using a marker such as Ki67 or MIB1
may provide some additional information on the biological behaviour of lymphomas. This is
also true for endocrine tumours and gastrointestinal stromal tumours. Further ancillary
techniques may include staining with antibodies against p53 for Barret’s oesophagus or colitis-
Endoscopy and Histopathology
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associated dysplasia. Currently a number of markers are under investigation for a more
accurate identification of early neoplasia.
Histochemistry (histological special stains) searching for mucins or other substances, and
occasionally electron microscopy and genetic markers can also be applied on biopsy samples.
Many stainings can be performed on routinely formalin fixed material. Increasingly there is
some overlap, between immune histochemistry and molecular techniques since genetic
markers can be demonstrated also by immune histochemistry. This is for instance true for
large-bowel cancers with microsatellite instability (MS), where the products of the DNA repair
genes hMLH1, hMSH2 and MSH6, or the lack of them, can be demonstrated immune
histochemically. These products do not however cover the whole range of MS. DNA or RNA
extraction and genetic analysis remains important and there may even be a growing need.
5. The oesophagus
5.1. Inflammatory conditions
At  present,  there  is  no  ideal  scenario  for  a  biopsy  series  for  the  diagnosis  of  gastro-
oesophageal reflux disease (GORD). In general, it is accepted that changes in the squamous
mucosa are usually found in the distal oesophagus close to the squamo-columnar junction.
Biopsies from the squamous mucosa should be completed with biopsies from the cardia.
Histological changes indicative of gastro-oesophageal reflux are indeed found at both sides
of  the  squamo-columnar  junction.[18-21]  The diagnosis  of  this  condition,  called carditis,
which  occurs  in  the  absence  of  signs  of  gastritis  in  the  antrum  and  corpus  due  to
Helicobacter pylori or other causes of gastritis implies also biopsies of antrum and corpus
in order to exclude the presence of these causes. A biopsy run for GORD should therefore
ideally include samples from the distal oesophagus, particularly from the Z-line and at 2
cm above, from the cardia distal to the Z-line and from the stomach.[22, 23] However, in
most cases, peptic oesophagitis due to GORD - the most common inflammatory condition
of the oesophagus - does not require biopsy diagnosis for those patients presenting with
typical symptoms and macroscopic endoscopic alterations.[24]
Biopsies are mainly useful in patients presenting with normal endoscopy and abnormal acid
exposure (non-erosive reflux disease – NERD), in patients with typical symptoms and normal
endoscopy and pH-metry or in patients with atypical symptoms. The presence of “dilated
intercellular spaces (DIS)” or of a combination of DIS with other microscopic features such as
basal zone hyperplasia observed in GORD may confirm the suspected diagnosis of reflux.[21]
There are however several other types of oesophagitis. The presence of an intense eosinophil
infiltration must orient towards a diagnosis of eosinophilic oesophagitis. Eosinophilic
oesophagitis can present a typical endoscopic pattern known as “ringed oesophagus” but the
oesophagus can appear normal in up to 20% of the patients. It is important to recognise that
the eosinophilic infiltration may have a heterogeneous distribution within the oesophagus.
Therefore, when considering eosinophilic oesophagitis, it is critical to have biopsies from
multiple areas, including the distal, mid, and proximal oesophagus.[25] Biopsies of the
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oesophagus are further indicated in the presence of oesophageal ulcers, erosions or an atypical
aspect or topography and whenever an infectious aetiology is suspected. They can help to
identify infections such as moniliasis, herpes and cytomegalovirus disease. (Fig. 5)
Figure 5. Gastric biopsy showing several Cytomegalovirus nuclear inclusions
Barrett's  oesophagus presents  a  special  problem.  One definition of  Barrett’s  oesophagus
implies  “endoscopic  abnormalities  suggestive  of  Barrett’s  oesophagus  (endoscopically
suspected oesophageal metaplasia) and the presence of columnar epithelium in biopsies.
Barrett’s oesophagus is a preneoplastic condition.[26] Effective management of the risk for
oesophageal adenocarcinoma in Barrett’s oesophagus requires precise detection of intestinal-
type metaplasia and dysplasia. The detection of intestinal metaplasia is subject to significant
sampling  error.[27]  (Fig.  6)  Intestinal  metaplasia  increases  with  segment  length  of  the
Barrett’s mucosa and detection improves with the number of biopsies taken.[28] Intestinal
metaplasia can be missed easily when only one or two biopsies are obtained. Therefore it
has been proposed to take multiple, closely spaced biopsies. One protocol proposes four-
quadrant biopsies every 1 cm for circumferential metaplastic segments (in short segment
Barrett’s oesophagus) or 2 cm (in long segment Barrett’s oesophagus).[3] In another study
it was proposed that 8 random biopsies should be obtained. With 1 – 4 biopsies the yield
of intestinal metaplasia was 35%.[6, 28] At the histological level, the detection of intestinal
metaplasia can be increased by using mucin stains. or immunohistochemistry. It has been
suggested that the presence of acidic mucins (blue on alcian blue stain) is a characteristic
feature even in the absence of goblet cells. However, this theory has not been confirmed.
Comparable disputed results have been obtained with immunohistochemical stains for CKs
and MUC antigens.
Endoscopy and Histopathology
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Figure 6. Oesophageal biopsy showing intestinal metaplasia in glands buried underneath the squamous epithelium
5.2. Neoplastic conditions
As the major risk of patients with Barrett’s oesophagus is to develop an adenocarcinoma, there
has been considerable interest in defining a subgroup of patients at risk. At the present time,
the identification of dysplasia in endoscopic mucosal biopsies is the standard method to detect
these patients. Systematic four-quadrant biopsy is considerably more effective for the detection
of dysplasia in Barrett than non-systematic biopsy sampling.[29] Non-adherence to a protocol
during surveillance leads to under-diagnosis or missed diagnosis because of sampling error.
[30] However, problems with inter-observer agreement, particularly for low–grade dysplasia,
on biopsy specimens have raised concern about the ability of pathologists to provide a
consistent and accurate diagnosis upon which management decisions can be based.[31, 32] In
order to reduce sampling errors, guidelines for the surveillance have been established by
national and international societies. In the future, the diagnostic yield for dysplasia will
however essentially be improved and sampling errors will be reduced by targeted biopsies.
These can be obtained with the help of endoscopic procedures such as chromo-endoscopy and
light- or laser-induced fluoroscopy.[33, 34]
High-grade dysplasia and early cancer can be treated by mucosal destructive or ablative
techniques. Some techniques such as photodynamic therapy and laser therapy do not allow
any histological study as their goal is complete destruction of the neoplastic tissue. Follow up
biopsies can however show remnants of metaplastic and even neoplastic tissue buried
underneath squamous epithelium. The frequency of buried metaplastic glands may be as high
as 51% of cases. These glands may be difficult to identify on small endoscopic biopsies.
Endoscopic mucosal resection (EMR) is an ablative technique originally developed as a
diagnostic procedure (strip-off biopsy) in the early 1980s but has now gained considerable
attention as a potential curative form of therapy for patients with high grade dysplasia and
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superficial cancers. It is also a good tool for histological staging because the procedure allows
to remove intact mucosa and submucosa enabling complete evaluation of mucosal and
submucosal invasion. EMR as a diagnostic tool has been shown to be superior to mucosal
biopsy and inter-observer agreement of Barrett’s oesophagus related dysplasia is significantly
better compared with biopsy specimens.[35] The presence of a double layer of muscularis
mucosae, which is a hallmark of Barrett’s oesophagus, is an important landmark. Only when
invasion extends beyond the deeper layer (the genuine muscularis mucosae), a diagnosis of
submucosal invasion is justified.[36]
Endoscopic biopsies are also commonly used for the diagnosis of cancer of the oesophagus
and the distinction between squamous cell carcinoma and adenocarcinoma. Two samples can
provide a positive diagnosis in 95.8% of cases. The addition of four samples increases the
positive yield to 100%. There is no statistically significant difference in the yield according to
the site and type of growth.[37] However, in strictures the diagnosis can be difficult. In this
situation, the additional use of brush cytology may increase the diagnostic yield. Soft tissue
tumours and lymphomas are less common in the oesophagus. The so-called Abrikosoff tumour
or granular cell tumour, a relatively rare lesion, may present a problem as the overlying
squamous epithelium can show hyperplasia which might be confused with neoplastic changes.
The tumour itself is composed of aggregates of round cells with a characteristic granular
cytoplasm showing S100 positivity with immunohistochemical stains. If the biopsy samples
are too superficial, the diagnosis can however be difficult. Fine needle aspiration biopsy could
be used for the former, although most soft tissue tumours of the oesophagus are not malignant.
Brush cytology can be helpful for the diagnosis of infections.
6. The stomach
6.1. Inflammatory conditions
Throughout the GI tract, mucosal features such as redness, oedema, swelling, bleeding,
erosions and ulcers can be observed. They reflect inflammation and tissue damage but may
also be due to mucosal atrophy and epithelial metaplasia. Metaplasia is most readily detected
endoscopically in the distal oesophagus but it is also common in the stomach. In the latter it
may appear as small red depressions simulating erosions or aphthoid ulcers, as an irregular
nodular area or as larger geographic red areas. The red colour and a depressed or nodular
appearance can be explained by thinning of the mucosa due to atrophy and increased visibility
of the vessels. Pathology is useful to confirm the endoscopic abnormality and probable
diagnosis, or to exclude such abnormalities or give another explanation. A depressed red spot
can indeed be a genuine erosion but it may also represent a vascular ectasia or a small area of
mucosal atrophy. Inflammatory conditions in the stomach include gastritis and reactive
gastropathy (chemical gastropathy, bile reflux). The latter is characterized by epithelial
damage and a minimal inflammatory cell reaction. Several types of gastritis can be
distinguished and histopathology plays a major role in this distinction. An aetiology-based
classification was proposed in the Sydney system at the World Congress of Gastroenterology
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in 1990 and updated in 1994.[38, 39] The Sydney system also established the need for taking
different biopsies of the gastric mucosa.[38] The guidelines include a) two biopsies of the
corpus and two of the antrum for an overall assessment of the distribution of the gastritis and
the distinction between antral gastritis, corpus gastritis and pan gastritis; b) one biopsy of the
angulus because atrophic gastritis and intestinal metaplasia are related with the development
of gastric cancer and occur most commonly at the angulus; c) the same area is the most
appropriate area to look for the presence of dysplasia. In small children, this approach may
however not be appropriate. Two samples from the stomach may be sufficient. Biopsy
diagnosis should include the morphological site or sites, the morphological lesions present,
and any potential cause. The sensitivity and specificity for the diagnosis of Helicobacter pylori
gastritis are high, varying between 88 and 99% for the former and 90 and 100% for the
specificity. The negative predictive value is near 100% for antral biopsies. Active gastritis, or
gastritis with neutrophils is often Helicobacter pylori positive and will imply treatment,
whether activity is mild, moderate or severe. Grading atrophy and intestinal metaplasia is less
reproducible.[40] Staging of gastritis has been proposed among others by the so-called OLGA
system but may be difficult to apply in routine practice.[41] Grading and staging could
however be useful for the identification of patients at risk for cancer. In addition to the gastric
biopsies ii seems reasonable to obtain, during the first diagnostic examination, also duodenal
biopsies to look for the presence of mucous surface (gastric) metaplasia, a requirement for
Helicobacter pylori colonisation of the duodenum which can induce duodenal ulcers, or for
epithelial lymphocytosis. If the stomach biopsies are normal and duodenitis is found on
histopathology, a Helicobacter pylori-induced duodenitis is highly unlikely. If the patient has
lymphocytic gastritis of the antrum and epithelial lymphocytosis in the duodenum, a diagnosis
of celiac disease should be suspected. Follow-up biopsies for gastritis can be considered when
a treatment for HP has been given in order to assess eradication or when intestinal metaplasia
and atrophy are very extensive.
Whenever special forms of gastritis are suspected multiple biopsies are needed. Histopathol‐
ogy can identify a variety of pathogens in infectious gastritis. Many of the special types lack
endoscopic abnormalities. Lymphocytic gastritis can present as a hypertrophic variant with
erosions and thickening of the gastric wall suggestive of Menetrier’s disease. It can be diffuse
or corporeal and correspond in these forms to varioliform gastritis. It can also be limited to the
antrum and in this case includes various conditions ( reflux gastritis, HP gastritis or coeliac
disease) must be considered. [42] The histopathology of gastroduodenal Crohn’s disease
includes a wide spectrum of changes, including the presence of granulomas as well as focally
enhanced (active) gastritis.[43] A correct diagnosis of Crohn's disease of the stomach can be
reached more accurately when multiple samples of the suspected sites (n=5) and of normal
sites are available. Granulomas can be detected in biopsies from macroscopically abnormal
mucosa as well as in biopsies from normal mucosa. The frequency of detecting granulomas
varies between 4.6% and 26% depending upon the presence of endoscopic lesions, the number
of biopsies and the number of sections examined. Multiple biopsies will increase the diagnostic
yield. Focally enhanced or focally active gastritis is typified by small collections of lymphocytes
and histiocytes surrounding a small group of foveolae or gastric glands, often with infiltrates
of neutrophils. Several studies have found that focally enhanced gastritis is common in adult
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Crohn’s disease patients. However, studies that used control groups have reported a
prevalence of focally enhanced gastritis in non-IBD patients in up to 19.4%. Therefore, this type
of gastritis may not be a good marker for the diagnosis of IBD or IBD-related gastritis in adults.
[44, 45] It may still be a good marker in children although it may not reliably distinguish
between Crohn’s disease and ulcerative colitis. Some studies have found that focally enhanced
gastritis is present in up to 20% of paediatric ulcerative colitis patients, suggesting that this
type of gastritis is a marker of IBD in general in children.
Biopsies are less indicated for the diagnosis of vascular abnormalities. They can however
be useful for the diagnosis of “gastric antral vascular ectasia” (GAVE). GAVE is a rare
condition (prevalence approximately 3/10000 upper endoscopies), characterised by red spots
in linear array in the antrum of the stomach. Based on the striped features from the antrum
at  endoscopy,  the  disorder  has  been called  the  “watermelon”  stomach.  The  histological
lesion consists of numerous dilated vessels in the mucosa, often with microthrombi, with
fibromuscular  hyperplasia  and  fibrohyalinosis  of  the  perivascular  lamina  propria.  The
mucosa shows no or mild chronic inflammation or atrophy with intestinal metaplasia.[46]
GAVE must  be distinguished from “portal  hypertensive gastropathy” and from “gastric
vascular ectasia”.[47]
6.2. Neoplastic conditions
In patients with marked atrophic gastritis or pernicious anaemia, the possibility of endocrine
cell hyperplasia and dysplasia needs to be considered, and immunostains can readily answer
this question. In patients with endocrine tumours (carcinoïds), the issue is whether these are
sporadic, associated with atrophic gastritis, or even multiple endocrine neoplasia (MEN) and
Zollinger-Ellison syndrome. Biopsies of adjacent gastric body mucosa will show whether there
is hyperplasia of parietal cells without atrophy as in Zollinger Ellison and MEN, atrophy as
seen in pernicious anemia, or normal mucosa as seen in sporadic endocrine tumours.
The macroscopic differential diagnosis between benign and malignant ulcers of the stomach
is correct, on average, in only 75% of cases (52% to 94% of cases depending on the series
reported in the literature).[3] Hence, the differential diagnosis can depend upon histology.
Chromo-endoscopy with targeted biopsies will change the guidelines in the future.
In the series reported in the literature, the proportion of cancer-positive biopsies varies
between 49% and 56% and about 25% of the biopsies are considered inadequate. A method of
biopsy by quadrants with a technique that avoids the lesion to be covered by the bleeding from
earlier biopsies reduces the number of unusable biopsies to 5.7% and increases the proportion
of cancer-positive biopsies to 67%. An average of 7 - 10 biopsies is required to reach enough
sensitivity and in order to avoid false negative results.[48, 49] When gastric lymphoma is
suspected multiple biopsies are also required. If the lesion presents as an ulcer, biopsies from
the edge (as for carcinoma) and the ulcer base should be obtained. Proper fixation (in order to
allow additional tests such as immuno-histochemistry and Polymerase Chain Reaction) is
absolutely indicated.
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Histopathology is also very useful for the identification of metastases or secondary malignant
involvement of the GI tract a problem which is becoming more common. Breast and melanoma
are the most frequently found. Approximately 1 metastasis is observed per 3847 upper GI
endoscopies and 1 lower metastasis per 1871 colonoscopies. The stomach and duodenum are
the most common locations. Immune histochemistry for cytokeratin patterns and other
markers can help to identify the primary origin if needed.
Overall a microscopic diagnosis of polyps (elevated lesions) depends on the type of the lesion
and the size and number of biopsies. Polyps of epithelial origin can be diagnosed with classical
pinch biopsies. They include benign lesions such as fundic gland polyps and neoplastic lesions
such as adenomas or neuro-endocrine dysplasia. A complete evaluation may need larger snare
biopsies and implies orientation. This is also needed for EMR specimens from early –
superficial gastric cancer and adenomas. As in Barrett’s oesophagus, a good orientation is
essential for the assessment of the risk factors for residual tumour and the need for additional
surgery. In contrast with the oesophagus, soft tissue tumours are more common in the stomach.
These are usually gastrointestinal stromal tumours (GIST). These tumours show a positive
staining with antibodies directed against CD117, DOG1 and often also for CD34 (87% positive
cases in the stomach). They produce polypoid lesions with a smooth or ulcerated surface as a
result of a submucosal process. Such a process can be inflammatory or tumoral and will often
not be diagnosed adequately when the surface is intact and only mucosal biopsies are available
(because of the superficial nature of these biopsies).
7. The duodenum
7.1. Inflammatory conditions
In the duodenum, inflammatory lesions include Helicobacter-associated disease, and other
infections, malabsorption, drug-associated disease and the pathology of the papilla of Vater.
Many GI diseases or systemic diseases (Helicobacter pylori, Crohn’s disease, vasculitis,
eosinophilic infiltrates) affect both the stomach and duodenum. Therefore, if duodenal
biopsies are taken for any reason it is good to include biopsies of the antrum, in addition. Any
duodenitis, inevitably raises the question of whether the condition may be associated with
Helicobacter or drugs and biopsies of the antrum can solve this issue readily. Histopathology
of the duodenum alone is indeed less useful for the diagnosis of Helicobacter pylori. Cytology
is superior with a sensitivity which varies between 56% and 100% and a specificity between
58% and 93% depending on the coloration (modified Giemsa seems superior).[50]
Histopathology is certainly adequate for the diagnosis of other infections such as Giardia
lamblia and strongyloides stercoralis.
A subtle increase of eosinophils in the duodenum may be associated with allergy and
functional dyspepsia.[51]
Biopsy of the small intestine remains superior for the diagnosis of Whipple’s disease and it is
the gold standard for the diagnosis of celiac disease. Biopsies of the descending duodenum,
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rather than the more distal intestine seem sufficient for the diagnosis of celiac disease. Jumbo
forceps have no marked advantage over standard size biopsies.[52] Due to the patchy nature
of villous changes, multiple biopsies are necessary. It has been suggested that at least four
endoscopic biopsies must be taken.[53, 54] Ideally, the specimens are oriented properly in
order to allow adequate assessment of villous height and crypt depth. The specimens can
therefore be immersed in the fixative after being placed on a Millipore filter paper, luminal
side upwards.
The recognition of the spectrum of histological changes in celiac disease as classified by Marsh
or modifications of this classification has provided a major advantage in the diagnosis. The
earliest lesions have still a normal villous architecture but show intraepithelial lymphocytosis
( >30-40 per 100 epithelial cells).[55] An intraepithelial lymphocytosis is not, however specific
for celiac disease and may be seen in infective enteropathies, Crohn’s disease, non steroidal
anti-inflammatory drug usage, giardiasis and other conditions. Furthermore, celiac disease is
not the only possible cause of subtotal or total villous atrophy. Other possibilities such as
autoimmune enteropathy must be considered, especially in neonates, but also in adults.
Serology remains therefore and important diagnostic tool. Histopathology is also essential for
the diagnosis of rare congenital disorders such as microvillous inclusion disease and “tufting
enteropathy” (also called intestinal epithelial dysplasia, with the term dysplasia used in its
ethymological meaning of “malformation” ; the pathology is due to defects in cell adhesion
due to defects in the EpCam gene).
7.2. Neoplastic conditions
Refractory sprue is a condition that appears to consist of several diseases, including
collagenous sprue and enteropathy-type T-cell lymphoma (ETL). Histology can help identify
these.[56]
Duodenal biopsies are also indicated in patients presenting with duodenal polyps. Many of
these, especially in the first duodenum, are benign lesions and represent inflammatory polyps
or ectopic gastric tissue.
Malignant  small  bowel  tumours constitute  less  than 5% of  GI  malignancies.  Four major
different  histological  types  of  malignant  small  bowel  tumours  can  be  distinguished  :
adenocarcinomas, endocrine tumours, lymphomas and soft tissue tumours. Adenocarcino‐
ma is the most common type. As in the large bowel, most adenocarcinomas arise from pre-
existing  adenomas  that  occur  sporadically  or  in  the  context  of  familial  adenomatous
polyposis (FAP), hereditary nonpolyposis colorectal cancer (HNPCC) or variant syndromes.
In  patients  with  FAP  "adenomas"  are  most  commonly  found  in  the  duodenum.  In  a
prospective study of 100 patients upper GI endoscopy revealed adenomatous polyps in the
duodenum in 33. They occur mainly in the second part of the duodenum but may involve
also the  first  and third part.  A special  staging system for  duodenal  polyposis  has  been
designed whereby the lesions were subdivided in different stages according to the polyp
number, size and histological type. The histological part of this system distinguishes the
various  types  of  polyps  and grades  of  dysplasia.  The  types  are  :  tubular/  hyperplastic/
inflammatory polyp =  1  point;  tubulo-villous =  2  points;  villous =  3  points;  dysplasia  is
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graded into mild = 1 point, moderate = 2, severe = 3. [57] Other polyps that may occur in
the duodenum or sporadic hamartomas or Peutz-Jeghers polyps and polyps observed in
other non-adenomatous polyposis syndromes.
Endocrine tumours of the small intestine include well differentiated neuro-endocrine tumours
and malignant large cell neuro-endocrine carcinomas. In the GI tract, most endocrine tumours
occur in the small bowel (29% of total) with the highest frequency in the ileum. Endoscopic
biopsies are often negative because of the superficial nature of the samples.
Lymphomatous infiltrates in the GI tract are frequently found as part of a disseminated disease.
Primary GI lymphoma defined as an extra-nodal lymphoma arising in the GI tract with bulk
of the lesion in this site, is a rare disorder. These lymphomas represent 5 to 10% of all Non
Hodgkin lymphomas. Despite the fact that the small intestine is the preferential part of the gut
where the mucosa associated lymphoid tissue (MALT) is localized, less than 25% of the GI
lymphomas affect the small intestine.
The duodenum is  also  the  site  of  the  papilla  of  Vater  where  the  extra-hepatic  bile  and
pancreatic ducts end. Tissue histopathology may be obtained during endoscopic retrograde
cholangiopancreatography (ERCP) by brushing, biopsy, bile aspiration or a combination of
these. Biopsies of the bile ducts have a specificity between 90% and 100% with a sensitivity
between 43% and 81% for the diagnosis of cholangiocarcinoma. Brush cytology has a similar
high specificity of nearly 100% but sensitivity is lower ranging from 18% - 60%. The low
sensitivity is linked to low cellularity of many of these tumours. Repeated brushing may
increase the yield. During ERCP, miniature cholangioscopes can be used and with these
endoscopes, directed tissue biopsies can be obtained. The biopsies are usually smaller than
standard forceps biopsies of the GI tract and may be inadequate in up to 28% of the samples.
[58]  However,  with  more  modern  equipment  adequate  tissue  for  examination  can  be
obtained.[59]
8. The terminal ileum and colon
8.1. Inflammatory conditions
Ileocolonoscopy is an important tool for the diagnosis of diarrhoea and colitis. Several studies
show that colonoscopy and biopsy is useful in the investigation of patients with chronic
diarrhoea yielding a histological diagnosis in 22 –31% of patients who had a macroscopically
normal colon at colonoscopy.[60-63] Histological diagnosis includes a variety of conditions
such as spirochetosis, pseudomelanosis coli, collagenous colitis and lymphocytic colitis and
variant forms.(Fig 7) The correct diagnosis of collagenous colitis implies multiple biopsies from
different segments because thickening of the collagen layer can be discontinuous.[64]
Histopathology can also help to identify amyloidosis and rare metabolic lysosomal or storage
disorders such as Tangier disease and systemic diseases such as mastocytosis.[65]
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Figure 7. Biopsy from the colon showing thickening of the subepithelial collagen table in collagenous colitis
In inflammatory diarrhoea, a precise diagnosis and differential diagnosis between infections
and IBD and between ulcerative colitis and Crohn’s disease is important for therapy and
follow up. Histopathology can identify a variety of pathogens such as amoeba, schistosoma
and Cytomegalovirus.  In transplant  patients  a  diagnosis  of  Graft  versus host  disease or
Cord Colitis can be confirmed and graded.[66] A correct diagnosis of ulcerative colitis can
be made by the pathologist  without clinical  information in 64% of  the cases with rectal
biopsies only and in 74% of the cases when multiple biopsies from different segments of
the  colon,  including  the  ileum  are  available.[10,  67]  With  clinical  information  a  correct
diagnosis  is  reached in  more than 90% of  the  cases.  A diagnosis  of  Crohn’s  disease  on
endoscopic samples of the colon relies particularly on the analysis of multiple biopsies from
different segments of the colon including the ileum.[68] Analysis of multiple biopsies yields
a positive diagnosis of Crohn’s disease in 64% of the cases compared to 24% for one single
rectal  biopsy.[64,  69]  Biopsies  of  the  terminal  ileum  are  mainly  useful  in  patients  with
inflammatory diarrhoea.[70, 71] The differential diagnosis between infections and IBD relies
on the distribution of the inflammatory infiltrate in the lamina propria and the presence of
architectural  changes.  Focal  or  diffuse  basal  plasmacytosis  is  a  strong  predictor  for  the
diagnosis of IBD, especially ulcerative colitis (occurring in over 70% of the patients). It is
only rarely observed in infectious colitis (+/- 3% of the patients). Structural epithelial changes
include the presence of an irregular surface, sometimes called pseudovillous or villiform
surface and a disturbed crypt architecture.[72-74]
Atypical presentations such as ulcerative colitis with left-sided colitis and peri-appendicular
inflammation or caecal patch are occasionally observed. However, the major clinical conditions
where endoscopic and histological lesions may not be characteristic include initial onset of the
disease, inflammatory diarrhoea in children, patients with liver disease and IBD, patients
under treatment and patients presenting with severe, fulminant disease. Colonic biopsies from
children between 1 and 10 years of age, presenting with new-onset ulcerative colitis show
significantly less crypt branching, plasma cells in the lamina propria, cryptitis, crypt abscesses,
and epithelial injury when compared with samples from adults. In 4 to 8% of cases the initial
biopsy samples are completely normal. Rectal sparing has been well documented.[75, 76]
Rectal sparing and patchy and focal inflammation are also more common in patients with
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primary sclerosing cholangitis (PSC) without clinically overt colitis, when compared to
patients with ulcerative colitis without PSC.[77, 78]
When the differential diagnosis between ulcerative colitis and Crohn’s disease can not be
solved with endoscopic biopsies the patient should be categorized as “IBD unclassified”.[79]
Clinical and histo-pathological follow up will eventually solve the diagnosis in most cases.
During follow up of IBD, histopathology can identify persistent active inflammation in
ulcerative colitis more reliably than endoscopy.[80] Persistent microscopic inflammation may
be important in the pathogenesis of dysplasia in IBD.
A complication of Kock pouch and ileal pouch anal anastomosis (IPAA) is the development
of a primary inflammation within the pouch which is associated with a clinical syndrome
termed “pouchitis”. This condition is common after surgery for ulcerative colitis, but can occur
also after surgery for other indications. Pouch biopsy specimens from well functioning
pouches can show mild villous shortening and chronic inflammation. The most consistent
finding in pouchitis is ulceration. Grading of pouchitis depends on clinical features, endoscopic
findings and histology. The degree of polymorphonuclear infiltration and the proportion of
ulcerated area are items of the score. There are no guidelines for the number and location of
biopsies from a pouch but there is some evidence that a biopsy, taken 5 cm above the ileoanal
anastomosis from the posterior and anterior wall may be the most sensitive for a diagnosis of
pouchitis. Pouchitis must be distinguished from “cuffitis” or “short-strip pouchitis”, which is
inflammation in the columnar cuff mucosa distal to the pouch. The top end of the anal canal
is lined by columnar mucosa like that of the rectum. In a hand sewn pouch-anal anastomosis,
this mucosa is stripped, albeit often incompletely since the junction between columnar
epithelium and squamous or transitional epithelium is difficult to distinguish. Islands of
columnar mucosa may be left behind.
Histology is also important for the differential diagnosis of eosinophilic disorders of the
gastrointestinal tract. Eosinophils are constitutively present in the gastrointestinal mucosa
outside the  oesophagus and the  precise  normal  numbers  have not  been defined.  In  the
colon geographical and seasonal differences in numbers have been observed. In humans,
appendix, caecum and ascending colon contain the highest numbers Therefore a diagnosis
of eosinophilic (gastro-)enteritis is difficult. An intraepithelial position of eosinophils may
be the most reliable marker of disease. Eosinophilic disorders can be separated into primary
(idiopathic) and secondary diseases, primary having no known cause, and secondary due
to other illnesses associated with eosinophilia such a infections, celiac disease, IBD and drug
related  pathology.  A  third  situation  is  observed  in  the  hypereosinophilic  syndrome,  a
heterogeneous group of  rare  diseases  defined by persistent  blood eosinophilia  for  more
than 6 months with evidence of organ involvement (blood eosinophilia > 1500/mm3).
Primary eosinophilic enteritis has been called allergic gastro-enteropathy, because a subset of
patients have an associated allergic component. Although considered idiopathic, an allergic
mechanism may be involved as most patients exhibit increased food-specific IgE levels.
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8.2. Neoplastic conditions
Crohn’s disease and ulcerative colitis carry an increased cancer risk. A pathway of “colitis –
dysplasia – cancer” has been identified and this allows surveillance of patients with an
increased risk (longstanding disease; extensive colitis; ulcerative colitis with primary
sclerosing cholangitis…).(Fig. 8) It has been estimated that 33 to 64 biopsies are required to
detect dysplasia with 90% and 95% probabilities respectively. Yet, with 20-40 biopsies less than
0.1% of the colorectal mucosa is covered.[81, 82] Current practice guidelines recommend that
4 biopsy specimens be taken from every 10 cm (0.05 % of the entire area of the colon) of diseased
bowel in addition to macroscopically atypical lesions.[83] However, the detection rate of IBD-
related dysplasia can substantially be improved with targeted biopsies obtained with the
newly developed endoscopic techniques and this procedure should replace the random biopsy
guidelines in the future.[84] Dysplasia in IBD can appear as polypoid lesions or as flat lesions.
Polypoïd lesions can occur in a mucosa with signs of colitis, or in a mucosa with flat dysplasia.
Therefore, biopsies should be obtained from the elevated lesion and from the surrounding
tissue. The microscopic diagnosis of “dysplasia” is based on the presence of cytological and
architectural abnormalities showing “unequivocal, non-invasive (confined within the
basement membrane), neoplastic transformation of the epithelium excluding all reactive
changes”.[85] Biopsies positive for dysplasia can be subdivided into low-grade and high-
grade. The grade of dysplasia is determined by the features of the most dysplastic portion. The
two grade classification appears to be reproducible, although in general the agreement is better
for high-grade dysplasia. Because of the diagnostic problems related to dysplasia ancillary
techniques such as staining for p53 and AMACR can be applied on the tissue samples in order
to improve the diagnosis. P53/AMACR coexpression seems to be of potential value for
predicting neoplastic progression in ulcerative colitis patients with flat low grade dysplasia or
indefinite lesions.[86]
Figure 8. Raised polypoid lesion in a biopsy from a patient with ulcerative colitis showing microscopic features of dys‐
plasia : DALM
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Sporadic adenomas and polypoid “dysplasia” in IBD can be managed with endoscopic
techniques and complete local excision appears to be adequate. Endoscopic resection
specimens of IBD-related neoplasia should be handled properly, like all polypectomy
specimens. They should be removed entirely if possible. Sporadic small polyps can be handled
with a cold or hot biopsy forceps. While the latter can induce coagulation artefacts, the damage
usually does not prevent adequate histological interpretation. Larger polyps should be
oriented. The pathologist will identify the origin of the lesion, epithelial or not and the nature :
neoplastic or not.
In recent years it has become clear that hyperplastic polyps are a heterogeneous group of
lesions, now reported as “serrated lesions”. They include benign polyps, so called (traditional)
hyperplastic polyps which can be subdivided in several types (microvesicular type, goblet-
cell-rich type and mucin-poor type) and lesions with a neoplastic potential. The distinction
between the hyperplastic subtypes has a high inter-observer variation and therefore routine
distinction of these subtypes is not necessary.[87] Among the lesions with a neoplastic
potential, traditional serrated adenomas, with cytological dysplasia and sessile serrated
adenomas or polyps have been identified. Both these lesions have a neoplastic potential
through the serrated neoplastic pathway. In sessile serrated polyps, the epithelial cells show
however some atypia or features of dysplasia.[88] Therefore a distinction is made between
sessile serrated adenomas with and without dysplasia. A proper diagnosis of sessile serrated
adenomas implies orientation of the endoscopic biopsy samples. The lesion is indeed
characterized by dilatation of the crypts from top to bottom. Epithelial serration and dilatation
are usually more prominent in the basal part of the crypts and this can not be evaluated
properly on tangentially sectioned samples.
Histopathology allows grading of dysplasia in polyps and determination of the tubular or
villous nature of the lesion. Tubular adenomas are by definition dysplastic and hence at
least low-grade dysplastic lesions. Identification of high-grade dysplasia and intramucosal
carcinoma  is  important.  Endoscopic  surveillance  of  patients  with  so-called  “advanced
adenoma” may need to  be  different  from that  performed in  patients  without  advanced
adenomas. In polyps, the occurrence of invasive cancer, must be differentiated from high-
grade dysplasia, intramucosal cancer and entrapped (pseudo-invasive) mucosa. Only when
cancer invades the submucosa, it is considered to have the potential to metastasize, although
lymphangiogenesis  can  occur  in  the  mucosa  as  shown  in  ulcerative  colitis.[89]  The
established histopathological criteria that determine the treatment options of polypectomy
versus subsequent surgical resection because of the risk of residual tumour are the status
of the resection margin, the histological grade, lympho-vascular invasion, budding of cells
and invasion into the submucosa below the stalk of the polyps but above the muscularis
propria. Various staging systems have been proposed for this purpose.[7, 90]
As in the stomach and the small intestine, lymphomas and mesenchymal tumours can also
occur in the colon and biopsies are suitable for a correct diagnosis.
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9. Conclusions
Histopathology plays a critical role in GI practice. Endoscopic biopsies are important in order
to establish, confirm or exclude a diagnosis suspected clinically or endoscopically, both in the
absence and presence of endoscopic abnormalities. Biopsy diagnosis is greatly facilitated when
the endoscopist provides adequate samples and understands the criteria used for histological
diagnosis. Histopathology plays also a major role in the design of therapeutic strategy. A close
collaboration between the endoscopist and the pathologist is therefore highly useful.
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